Mitchell & Pahl Private Wealth, LLC Novo Nordisk A S Transaction History

Mitchell & Pahl Private Wealth, LLC

$206 Million
Q4 2024

A detailed history of Mitchell & Pahl Private Wealth, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Mitchell & Pahl Private Wealth, LLC holds 12,599 shares of NVO stock, worth $968,359. This represents 0.52% of its overall portfolio holdings.

Number of Shares

12,599

Previous 12,175 3.48%

Holding current value

$968,359

Previous $1.45 Million 25.26%

% of portfolio

0.52%

Previous 0.69%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	BUY	$85.0 - $120.04 $36,040 - $50,896	424 Added 3.48%	12,599 $1.08 Million
Q3 2024 Oct 16, 2024	BUY	$119.07 - $145.42 $9,644 - $11,779	81 Added 0.67%	12,175 $1.45 Million
Q2 2024 Jul 12, 2024	SELL	$122.71 - $146.91 $27,732 - $33,201	-226 Reduced 1.83%	12,094 $1.73 Million
Q1 2024 Apr 26, 2024	BUY	$102.11 - $135.92 $27,773 - $36,970	272 Added 2.26%	12,320 $1.58 Million
Q4 2023 Feb 08, 2024	SELL	$87.78 - $105.45 $11,938 - $14,341	-136 Reduced 1.12%	12,048 $1.25 Million
Q3 2023 Oct 31, 2023	BUY	$90.94 - $199.54 $591,655 - $1.3 Million	6,506 Added 114.58%	12,184 $1.11 Million
Q2 2023 Aug 07, 2023	SELL	$155.98 - $172.65 $16,689 - $18,473	-107 Reduced 1.85%	5,678 $918,000
Q1 2023 May 05, 2023	BUY	$132.34 - $159.14 $8,072 - $9,707	61 Added 1.07%	5,785 $920,000
Q4 2022 Feb 09, 2023	BUY	$102.55 - $135.33 $12,613 - $16,645	123 Added 2.2%	5,724 $774,000
Q3 2022 Nov 01, 2022	BUY	$95.28 - $116.93 $37,159 - $45,602	390 Added 7.48%	5,601 $558,000
Q2 2022 Jul 25, 2022	BUY	$103.24 - $121.81 $51,103 - $60,295	495 Added 10.5%	5,211 $581,000
Q1 2022 Apr 14, 2022	BUY	$93.1 - $112.54 $67,311 - $81,366	723 Added 18.11%	4,716 $524,000
Q4 2021 Jan 19, 2022	BUY	$95.88 - $117.08 $27,805 - $33,953	290 Added 7.83%	3,993 $447,000
Q3 2021 Nov 03, 2021	BUY	$84.42 - $106.62 $5,740 - $7,250	68 Added 1.87%	3,703 $355,000
Q2 2021 Jul 14, 2021	BUY	$67.66 - $84.76 $19,350 - $24,241	286 Added 8.54%	3,635 $304,000
Q1 2021 Apr 29, 2021	BUY	$67.06 - $75.82 $6,907 - $7,809	103 Added 3.17%	3,349 $226,000
Q4 2020 Feb 09, 2021	BUY	$63.89 - $73.8 $207,386 - $239,554	3,246 New	3,246 $227,000

Others Institutions Holding NVO

# of Institutions

1,885

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $173B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell & Pahl Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell & Pahl Private Wealth, LLC with notifications on news.

Account

Mitchell & Pahl Private Wealth, LLC Novo Nordisk A S Transaction History